Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study ...

Surmodics (SRDX) announced the publication of the TRANSCEND clinical trial, a global randomized study demonstrating the SurVeil drug-coated ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the publication of the TRANSCEND clinical trial, a global ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the publication of the TRANSCEND clinical trial, ...

'It will be a very long rehabilitation' - No Tour de France for Fabio Jakobsen as he recovers from iliac artery surgery By Kirsten Frattini published 9 April 2025 'I came out of it in a very bad way.

This is primarily because these arterial roads serve as transit corridors for container trucks, tankers, and trailers heading to and from the region’s industrial and port hubs. With the Ennore ...

Get Instant Summarized Text (Gist) Pulmonary artery denervation (PADN) shows promise as an intervention for pulmonary hypertension, improving key hemodynamic parameters and clinical outcomes. A ...

The trial seeks to enrol up to 158 subjects with moderate-to-severely calcified, stenotic de novo coronary artery lesions. Credit: Pixel-Shot / Shutterstock. Johnson & Johnson (J&J) MedTech’s ...

Johnson & Johnson said Monday it has enrolled the first patient in a pivotal study of a device for clearing “difficult-to-cross” coronary arteries. Like other products made by J&J’s Shockwave Medical, ...

This paper thus investigated how to alleviate traffic congestion on an arterial road with a bottleneck via using eVTOL aircrafts to transfer passengers upstream the bottleneck to downstream. The ...